on Relief Therapeutics Holding SA (ETR:RLF)
MindMaze Therapeutics Announces 2026 AGM Plans
MindMaze Therapeutics Holding SA has released the invitation for its 2026 Annual General Meeting (AGM), set for June 25, 2026, in Geneva, Switzerland. The AGM will propose re-electing current Board members and nominating Brad Hollinger and Zach Henderson as new Board members.
The meeting's agenda includes reviewing the 2025 Annual Report and financial statements, appointing members to various committees, and voting on Board and Executive Committee compensation. Shareholders will vote on increasing the company's conditional share capital. Details are available on MindMaze's website.
MindMaze, a leader in neurotherapeutics, focuses on innovative care solutions integrating advanced software and AI for neurological disorders.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Relief Therapeutics Holding SA news